Canada markets close in 5 hours 59 minutes

Cullinan Therapeutics, Inc. (CGEM)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
22.19-0.35 (-1.55%)
As of 10:01AM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 1.30B
Enterprise Value 869.23M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)3.05
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) -0.00
52-Week Change 383.40%
S&P500 52-Week Change 323.33%
52 Week High 330.19
52 Week Low 37.64
50-Day Moving Average 321.44
200-Day Moving Average 314.04

Share Statistics

Avg Vol (3 month) 3775.89k
Avg Vol (10 day) 3607.85k
Shares Outstanding 557.63M
Implied Shares Outstanding 657.63M
Float 837.57M
% Held by Insiders 14.51%
% Held by Institutions 178.75%
Shares Short (May 15, 2024) 43.74M
Short Ratio (May 15, 2024) 42.85
Short % of Float (May 15, 2024) 47.54%
Short % of Shares Outstanding (May 15, 2024) 46.49%
Shares Short (prior month Apr 15, 2024) 41.68M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-22.15%
Return on Equity (ttm)-29.47%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -170.57M
Net Income Avi to Common (ttm)-132.35M
Diluted EPS (ttm)-3.13
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)433.01M
Total Cash Per Share (mrq)7.51
Total Debt (mrq)3.17M
Total Debt/Equity (mrq)0.74%
Current Ratio (mrq)20.33
Book Value Per Share (mrq)9.88

Cash Flow Statement

Operating Cash Flow (ttm)-121.53M
Levered Free Cash Flow (ttm)-81.68M